Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR1405-01 injection for postoperative orthopedic pain
CTR20254614Phase 3Active
- Sponsor
- Nanjing Hairong Pharmaceutical Technology
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HR1405-01 in postoperative pain, postoperative pain (after orthopedic surgery), sponsored by Nanjing Hairong Pharmaceutical Technology. Started Apr 2026; status: active.
02
Drugs
HR1405-01
03
Conditions
postoperative painpostoperative pain (after orthopedic surgery)
Beyond the preview
Go deeper on CTR20254614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254614.